Á lódáil...
Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?
BACKGROUND: In clinical practice the gold standard method to assess BRAF status in patients with metastatic melanoma is based on molecular assays. Recently, a mutation-specific monoclonal antibody (VE1), which detects the BRAF V600E mutated protein, has been developed. With this study we aimed to co...
Na minha lista:
| Foilsithe in: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
BioMed Central
2016
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5116153/ https://ncbi.nlm.nih.gov/pubmed/27863476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2951-4 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|